Neuralink will begin human trials in Canada, NYTimes says OpenAI deleted evidence in its copyright lawsuit, and Chemists have created the world's thinnest spaghetti
Nov 22, 2024•10 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Neuralink gets approval to start human trials in Canada, The New York Times says OpenAI deleted evidence in its copyright lawsuit, and Chemists have created the world's thinnest spaghetti. It has a medical use. It's Thursday, November 22nd and this is Engadget News.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
For the best experience, listen in Metacast app for iOS or Android